02.10.24 – 03.10.24 • London, United Kingdom (UK)
ELRIG Drug Discovery 2024
Myllia will be attending and sponsoring ELRIG's Drug Discovery 2024 meeting in London, UK! Meet Myllia's BD and R&D teams on site to explore CRISPR screens for early-stage R&D and target discovery
Myllia will present the CROP-Seq (Perturb-Seq) screening platform at booth B12 and during the Technology Spotlight presentation on Thursday, October 3 at 2.40 PM in the “Target Discovery and Disease Modelling” track. Don’t miss to engage with our team members Henrik, Tilmann and Christoph on site and discuss how our next-generation CRISPR screening platform can accelerate your drug target discovery/validation projects!
Booth B12
Technology Spotlight on Thursday, October 3 at 2.40 PM
Event website:
ELRIG Drug Discovery 2024
Attendee(s):
Henrik Schmidt (LinkedIn)
Tilmann Buerckstuemmer (LinkedIn)
Christoph Neumayr (LinkedIn)